2020 - Distinguished Fellows of the American Association of Immunologists (AAI)
2016 - AAI Excellence in Mentoring Award, American Association of Immunologists
2006 - Member of the National Academy of Medicine (NAM)
2002 - Member of the National Academy of Sciences
1999 - Fellow of the American Association for the Advancement of Science (AAAS)
1998 - Fellow of the Royal Society, United Kingdom
1988 - Member of Academia Europaea
1984 - Fellow of the Royal Society, United Kingdom
Member of the European Molecular Biology Organization (EMBO)
Richard A. Flavell spends much of his time researching Immunology, Cell biology, Molecular biology, Immune system and Signal transduction. His work is connected to Inflammation, Innate immune system, Inflammasome, Antigen and IL-2 receptor, as a part of Immunology. He interconnects Proinflammatory cytokine and Secretion in the investigation of issues within Inflammasome.
The Cell biology study combines topics in areas such as Cellular differentiation, Apoptosis and Cytotoxic T cell, Interleukin 21, T cell. His research investigates the link between Molecular biology and topics such as Locus that cross with problems in Chromatin. His Immune system study combines topics in areas such as Transforming growth factor beta and Cytokine.
His primary areas of study are Immunology, Cell biology, Immune system, Molecular biology and T cell. Inflammation, Cytokine, Innate immune system, Antigen and Immunity are the primary areas of interest in his Immunology study. His Antigen research incorporates elements of Antibody and Borrelia burgdorferi.
Within one scientific family, Richard A. Flavell focuses on topics pertaining to Cytotoxic T cell under Cell biology, and may sometimes address concerns connected to CD8. His work deals with themes such as Transforming growth factor beta and Virology, which intersect with Immune system. His Molecular biology research is multidisciplinary, relying on both Gene and DNA.
Richard A. Flavell mainly investigates Cell biology, Immunology, Immune system, Cancer research and Cytokine. His studies in Cell biology integrate themes in fields like Inflammation, T cell and Receptor, Innate immune system. His T cell study integrates concerns from other disciplines, such as Cytotoxic T cell, CD8 and Effector.
His Immunology research includes themes of Haematopoiesis and Inflammatory bowel disease. His biological study spans a wide range of topics, including Cell and Disease. His Cancer research research includes elements of Immune checkpoint and Immunotherapy.
His main research concerns Immunology, Cell biology, Immune system, T cell and Immunity. His study explores the link between Immunology and topics such as Haematopoiesis that cross with problems in Mesenchymal stem cell. His study in Cell biology is interdisciplinary in nature, drawing from both Inflammation, Receptor, Transcription factor and Cell growth.
His studies deal with areas such as Commensalism, Gut flora, Disease and Cancer research as well as Immune system. His T cell research incorporates themes from Cytotoxic T cell, Interleukin 10 and Effector. Richard A. Flavell combines subjects such as Innate immune system, Viral load and Virology with his study of Immunity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.
Lena Alexopoulou;Agnieszka Czopik Holt;Ruslan Medzhitov;Richard A. Flavell.
Nature (2001)
The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells
Wei-ping Zheng;Richard A Flavell.
Cell (1997)
Transforming growth factor-beta regulation of immune responses.
Ming O. Li;Yisong Y. Wan;Shomyseh Sanjabi;Anna Karin L Robertson.
Annual Review of Immunology (2006)
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Sally R. M. Bennett;Sally R. M. Bennett;Francis R. Carbone;Freda Karamalis;Freda Karamalis;Richard A. Flavell.
Nature (1998)
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Leo E. Otterbein;Leo E. Otterbein;Fritz H. Bach;Jawed Alam;Miguel P. Soares.
Nature Medicine (2000)
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
Keisuke Kuida;Timothy S. Zheng;Songqing Na;Chia-Yi Kuan.
Nature (1996)
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Jennifer M. Lund;Lena Alexopoulou;Ayuko Sato;Margaret Karow.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
Cathy Tournier;Patricia M. Hess;Derek D. Yang;Derek D. Yang;Jie Xu.
Science (2000)
Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.
Koichi S. Kobayashi;Mathias Chamaillard;Yasunori Ogura;Octavian Henegariu.
Science (2005)
BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX- and BAK-Mediated Mitochondrial Apoptosis
Emily H.-Y.A Cheng;Michael C Wei;Solly Weiler;Richard A Flavell.
Molecular Cell (2001)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
University of Massachusetts Medical School
Yale University
Hannover Medical School
University of Southern California
Centre d’Immunologie de Marseille-Luminy
University of California, Davis
Osaka Prefecture University
University of Vermont
Cedars-Sinai Medical Center
Johnson & Johnson
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: